PDL Biopharma, Inc. Strategy, SWOT and Corporate Finance Report
Summary
PDL Biopharma, Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.
Key Highlights
PDL Biopharma, Inc., PDL or 'the company', formerly known as Protein Design Labs, Inc., is engaged in the research and development of humanized antibodies for cancer, immunologic diseases and other medical conditions. The company operates in the US, where it is headquartered in Incline Village, Nevada.
Scope
Detailed information on PDL Biopharma, Inc. required for business and competitor intelligence needs
A study of the major internal and external factors affecting PDL Biopharma, Inc. in the form of a SWOT analysis
An indepth view of the business model of PDL Biopharma, Inc. including a breakdown and examination of key business segments
Intelligence on PDL Biopharma, Inc.'s mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about PDL Biopharma, Inc., such as business expansion, restructuring, and contract wins
Large number of easytograsp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of PDL Biopharma, Inc. and the factors that influence its strategies.
Track strategic initiatives of the company and latest corporate news and actions.
Assess PDL Biopharma, Inc. as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on PDL Biopharma, Inc.'s business structure, strategy and prospects.